COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.

ABSTRACT:

Background

Fifteen percent of patients with cancer experience symptomatic sequelae, which impair post-COVID-19 outcomes. In this study, we investigated whether a proinflammatory status is associated with the development of COVID-19 sequelae.

Methods

OnCovid recruited 2795 consecutive patients who were diagnosed with Severe Acute Respiratory Syndrome Coronavirus 2 infection between February 27, 2020, and February 14, 2021. This analysis focused on COVID-19 survivors who underwent a clinical reassessment after the exclusion of patients with hematological malignancies. We evaluated the association of inflammatory markers collected at COVID-19 diagnosis with sequelae, considering the impact of previous systemic anticancer therapy. All statistical tests were 2-sided.

Results</

SUBMITTER: Cortellini A 

PROVIDER: S-EPMC9047221 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature